| abstract |
The present invention provides methods for treating inflammatory conditions, rheumatoid diseases, autoimmune conditions, and conditions associated with bone loss, comprising administering to a subject with an inflammatory condition an amount effective to treat the condition of a compound selected from the group consisting of narcistatin, pancratistatin, pancratistatin-7' phosphate and pancratistatin-3',4' cyclic phosphate, or pharmaceutically acceptable salts thereof. |